Skip to main content
Signal8

Wirk Shaheen

SEC insider (Form 3/4/5 filer). CIK 0002050227. Director at Movano Inc. (MOVE) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2026. Located in PLEASANTON, CA.

Companies Wirk Shaheen has filed insider reports for

  • Movano Inc. (MOVE): Director
  • Tvardi Therapeutics, Inc. (TVRD): Director
Wirk Shaheen profile photo

Wirk Shaheen

CIK: 0002050227

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (6.3%)

Derivative conversions

Awards (A)12 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (18.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Movano Inc. logo
MOVE

Movano Inc.

Director
Tvardi Therapeutics, Inc. logo
TVRD

Tvardi Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Movano Inc. logo
    MOVE

    Movano Inc.

    Mar 13, 2026
    Exercise
    Direct
    10K shares at avg. $1.25$13K
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Jan 9, 2026
    Award
    Direct
    3K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Jan 9, 2026
    Award
    Direct
    3K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Nov 3, 2025
    Award

    Stock option (right to buy)

    Direct
    10K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Nov 3, 2025
    Disposition
    Direct
    6.8K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Oct 3, 2025
    Award
    Direct
    20.7K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    Jul 3, 2025
    Award
    Direct
    18.7K shares-
  • Movano Inc. logo
    MOVE

    Movano Inc.

    May 9, 2025
    Award
    Direct
    29.1K shares-
  • Tvardi Therapeutics, Inc. logo
    TVRD

    Tvardi Therapeutics, Inc.

    Apr 17, 2025
    Award

    Stock Option (right to buy)

    Direct
    12K shares-
  • Tvardi Therapeutics, Inc. logo
    TVRD

    Tvardi Therapeutics, Inc.

    Apr 15, 2025
    Award
    Indirect
    263.2K shares-

1-10 of 16